Free Trial

Aimei Health Technology (NASDAQ:AFJK) Releases Earnings Results

Aimei Health Technology logo with Financial Services background

Key Points

  • Aimei Health Technology (NASDAQ: AFJK) reported a quarterly EPS of $0.07, as stated by Zacks.
  • The company's stock price was relatively stable, trading at $11.17 with low trading volume compared to its average.
  • Aimei Health Technology is primarily focused on pursuing mergers and acquisitions in the biopharmaceutical and medical technology sectors.
  • Five stocks to consider instead of Aimei Health Technology.

Aimei Health Technology (NASDAQ:AFJK - Get Free Report) announced its quarterly earnings results on Wednesday. The company reported $0.07 earnings per share (EPS) for the quarter, Zacks reports.

Aimei Health Technology Price Performance

Shares of AFJK stock remained flat at $11.21 during trading hours on Monday. Aimei Health Technology has a 52 week low of $10.24 and a 52 week high of $11.30. The stock's 50-day moving average is $11.16 and its 200 day moving average is $11.05. The stock has a market capitalization of $68.61 million, a P/E ratio of 48.74 and a beta of -0.02.

Aimei Health Technology Company Profile

(Get Free Report)

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.

Recommended Stories

Should You Invest $1,000 in Aimei Health Technology Right Now?

Before you consider Aimei Health Technology, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aimei Health Technology wasn't on the list.

While Aimei Health Technology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.